Overall SDG Alignment Evaluation:
The Doctor of Philosophy Program in Clinical Sciences is fundamentally designed to produce researchers with in-depth knowledge and skills to create new knowledge and innovations for solving health problems. The program's core mission to conduct internationally recognized, interdisciplinary research makes it a powerhouse for achieving SDG 3 (Good Health and Well-being). By training experts in cutting-edge clinical research methodologies, including epidemiology, molecular biology, and proteomics, the curriculum is a key driver for SDG 9 (Industry, Innovation, and Infrastructure) within the biomedical and healthcare sectors. As an international, research-intensive doctoral program, it is a flagship for SDG 4 (Quality Education), cultivating the next generation of scientists. Through its requirement for internationally recognized research, the program fosters the global knowledge-sharing and collaboration essential for SDG 17 (Partnerships for the Goals).
SDG 3: Good Health and Well-beingAlignment Summary: This program is centrally focused on ensuring healthy lives by advancing clinical and translational research. The curriculum provides an advanced, research-intensive education on epidemiology, clinical immunology, pharmacology, and the molecular basis of diseases. It directly contributes to the research and development of new diagnostic tools, therapeutic strategies, and evidence-based clinical practices for a wide range of diseases.
| Course Code | Course Title | Alignment Rationale |
|---|---|---|
| MD567712 | Cells and Molecular Biology | Provides a deep understanding of cellular and molecular function, which is foundational for research into the mechanisms of both communicable and non-communicable diseases (Target 3.3, 3.4). |
| MD568711 | Clinical Epidemiology and Biostatistics | Directly supports efforts to combat epidemics and other health threats by studying disease distribution and determinants in populations (Target 3.D). |
| MD568712 | Good Laboratory and Clinical Practice | Ensures the quality and ethics of health research, which is essential for developing safe and effective new medicines and treatments (Target 3.B). |
| MD568721 | Clinical Immunology | Contributes to fighting communicable diseases by deepening the understanding of the immune system's role in disease, essential for developing vaccines and immunotherapies (Target 3.3). |
| MD568722 | Clinical Pharmacology and Toxicology | Aligns with research and development for health (Target 3.B) by focusing on drug action, development, and safety. |
| MD568723 | Molecular Biology of Diseases | Directly supports research to combat major non-communicable diseases like cancer and genetic disorders by focusing on their molecular basis (Target 3.4). |
SDG 4: Quality EducationAlignment Summary: As an international doctoral program, this curriculum is the epitome of quality education. It is designed to cultivate expert researchers and academics by providing advanced training in scientific research, ethics, and communication, fostering a culture of lifelong learning and contributing to the global knowledge economy in the biomedical sciences.
| Course Code | Course Title | Alignment Rationale |
|---|---|---|
| MD567714 | Medical Sciences Research Methodology | Provides the core research skills that define high-quality doctoral education, equipping students for high-level employment and lifelong learning in scientific research (Target 4.3 and 4.4). |
| MD568891/892 | Seminar in Clinical Science I/II | Enhances lifelong learning opportunities (Target 4.3) by providing a platform for critical analysis and discussion of current research, fostering the skills to create new knowledge. |
| Dissertation | Dissertation | Represents a capstone lifelong learning opportunity (Target 4.3), where students conduct original, in-depth research, acquiring superior skills for employment and innovation (Target 4.4). |
SDG 9: Industry, Innovation and InfrastructureAlignment Summary: The program is a catalyst for innovation in the biotechnology and pharmaceutical industries. By providing advanced training in cutting-edge fields like clinical proteomics, metabolomics, and molecular biology, it enhances scientific research and upgrades the technological capabilities of sectors focused on diagnostics, drug development, and personalized medicine.
| Course Code | Course Title | Alignment Rationale |
|---|---|---|
| MD567713 | Laboratory Techniques in Medical Sciences | Drives innovation (Target 9.5) by teaching advanced laboratory technologies that are critical for research and development in the biomedical industry. |
| MD568723 | Molecular Biology of Diseases | Enhances scientific research and innovation (Target 9.5) by applying cutting-edge molecular techniques to understand and combat disease, fostering development in the biotech and pharmaceutical sectors. |
| MD568724 | Clinical Proteomics and Metabolomics | Fosters innovation by providing expertise in cutting-edge technologies for biomarker discovery and diagnostics, which is critical for R&D in personalized medicine (Target 9.5). |
SDG 17: Partnerships for the GoalsAlignment Summary: The international nature of this program and its focus on globally relevant health issues inherently foster partnerships. The curriculum requires engagement with the international scientific community through seminars and research dissemination, promoting the knowledge-sharing and multi-stakeholder collaborations vital for achieving global health goals.
| Course Code | Course Title | Alignment Rationale |
|---|---|---|
| MD568891/892 | Seminar in Clinical Science I/II | Promotes the global partnership for sustainable development (Target 17.6) by requiring students to engage with and present on the latest international research, fostering a culture of global knowledge-sharing. |
| Dissertation | Dissertation | Represents a significant contribution to global partnerships (Target 17.16) by creating new, publishable knowledge that is shared internationally to solve critical global health challenges. |